We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.3B
AUM Growth
-$3.3B
(-7.6%)
Cap. Flow
-$1.89B
Cap. Flow
% of AUM
-4.68%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
1,160
New
85
Increased
251
Reduced
431
Closed
113
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVLR
Avalara, Inc.
AVLR
|
+$150M |
| 2 |
EOG Resources
EOG
|
+$128M |
| 3 |
TJX Companies
TJX
|
+$122M |
| 4 |
RTX Corp
RTX
|
+$107M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$365M |
| 2 |
Burlington
BURL
|
+$216M |
| 3 |
Textron
TXT
|
+$190M |
| 4 |
Dollar Tree
DLTR
|
+$126M |
| 5 |
ExxonMobil
XOM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.31% |
| 2 | Healthcare | 17.41% |
| 3 | Financials | 15.7% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$143B
| $210M | 0.52% |
4,809,341
-630,260
| -12% | -$30.6M |
|
27
Thermo Fisher Scientific
TMO
$213B
| $202M | 0.5% |
399,124
+11,700
| +3% | +$6.55M |
|
28
Merck
MRK
$322B
| $199M | 0.49% |
2,315,061
+801,685
| +53% | +$71.6M |
|
|
29
TJX Companies
TJX
$174B
| $195M | 0.48% |
3,137,648
+1,949,500
| +164% | +$122M |
|
|
ATVI
30
DELISTED
Activision Blizzard
ATVI
| $194M | 0.48% |
2,603,707
+49,033
| +2% | +$3.84M |
|
31
Hartford Financial Services
HIG
$38.9B
| $191M | 0.47% |
3,079,232
+536,700
| +21% | +$34.9M |
|
32
Wells Fargo
WFC
$261B
| $190M | 0.47% |
4,733,596
+42,100
| +0.9% | +$1.81M |
|
|
33
Textron
TXT
$14.7B
| $186M | 0.46% |
3,187,742
-3,003,209
| -49% | -$190M |
|
|
34
EOG Resources
EOG
$79.2B
| $184M | 0.46% |
1,647,100
+1,136,400
| +223% | +$128M |
|
|
SIVB
35
DELISTED
SVB Financial Group
SIVB
| $178M | 0.44% |
529,922
+27,293
| +5% | +$11M |
|
36
PepsiCo
PEP
$190B
| $177M | 0.44% |
1,085,779
-354,200
| -25% | -$61M |
|
37
Bank of America
BAC
$435B
| $174M | 0.43% |
5,754,273
+76,900
| +1% | +$2.57M |
|
38
Danaher
DHR
$137B
| $172M | 0.43% |
752,381
-160,063
| -18% | -$39.2M |
|
|
CHNG
39
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $166M | 0.41% |
6,032,173
+4,124,849
| +216% | +$102M |
|
40
Accenture
ACN
$102B
| $166M | 0.41% |
644,422
+9,800
| +2% | +$2.83M |
|
41
Walt Disney
DIS
$167B
| $165M | 0.41% |
1,748,900
-3,575
| -0.2% | -$383K |
|
42
Walmart Inc
WMT
$885B
| $164M | 0.41% |
3,785,001
-1,351,425
| -26% | -$59.2M |
|
43
Costco
COST
$422B
| $162M | 0.4% |
343,677
-117,900
| -26% | -$61.3M |
|
44
Bristol-Myers Squibb
BMY
$133B
| $158M | 0.39% |
2,225,995
+1,228,935
| +123% | +$89.1M |
|
45
Abbott
ABT
$183B
| $158M | 0.39% |
1,634,164
-189,400
| -10% | -$20.2M |
|
|
46
Dollar Tree
DLTR
$24.4B
| $158M | 0.39% |
1,159,714
-806,524
| -41% | -$126M |
|
47
NextEra Energy
NEE
$181B
| $157M | 0.39% |
2,001,813
-24,100
| -1% | -$2.04M |
|
48
Honeywell
HON
$77B
| $153M | 0.38% |
975,227
+494,639
| +103% | +$86.2M |
|
|
AVLR
49
DELISTED
Avalara, Inc.
AVLR
| $153M | 0.38% |
+1,670,000
| New | +$150M |
|
|
50
RTX Corp
RTX
$290B
| $152M | 0.38% |
1,860,447
+1,177,161
| +172% | +$107M |
|
Similar funds
Adage Capital Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Adage Capital Partners held 1,160 positions worth $40.3B, down 7.6% from $43.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.89B in Q3 2022, closing 113 positions and reducing 431 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $101M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Avalara, Inc. worth $153M.
- Adage Capital Partners's largest Q3 2022 buy was Avalara, Inc.: 1,670,000 shares worth $153M.
- Adage Capital Partners added most to EOG Resources in Q3 2022, an estimated $128M increase.
- Adage Capital Partners's biggest Q3 2022 reduction was Royalty Pharma, cutting an estimated $365M.
- Adage Capital Partners fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $101M.
- Adage Capital Partners's ten largest holdings make up 21% of its $40.3B portfolio in Q3 2022.
- Adage Capital Partners opened 85 new positions and closed 113 in Q3 2022.
- Adage Capital Partners's portfolio value fell 7.6% quarter-over-quarter to $40.3B.
Based on Adage Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.